Molecular Pharmaceutics · 2017 · 27 citations · 49 references
PharmacyMaterials SciencePharmaceuticsBioavailabilityComputational ChemistryNanomaterialsBioavailability ModelingDrug DissolutionDrug SolubilityKinetic ModelingMolecular DynamicsNanoparticle FormulationsComputational Solubility ModelingDissolution KineticsDissolution Of NanocrystalsDrug Dissolution KineticsNanoparticle DissolutionSolubilitySolubility BehaviorSolubility Prediction Models
Nanocrystals are receiving increased attention for pharmaceutical applications due to their enhanced solubility relative to their micron-sized counterpart and, in turn, potentially increased bioavailability. In this work, a computational method is proposed to predict the following: (1) polymorph specific dissolution kinetics and (2) the multiplicative increase in the polymorph specific nanocrystal solubility relative to the bulk solubility. The method uses a combination of molecular dynamics and a parametric particle size dependent mass transfer model. The method is demonstrated using a case study of α-, β-, and γ-glycine. It is shown that only the α-glycine form is predicted to have an increasing dissolution rate with decreasing particle size over the range of particle sizes simulated. On the contrary, γ-glycine shows a monotonically increasing dissolution rate with increasing particle size and dissolves at a rate 1.5 to 2 times larger than α- or β-glycine. The accelerated dissolution rate of γ-glycine relative to the other two polymorphs correlates directly with the interfacial energy ranking of γ > β > α obtained from the dissolution simulations, where γ- is predicted to have an interfacial energy roughly four times larger than either α- or β-glycine. From the interfacial energies, α- and β-glycine nanoparticles were predicted to experience modest solubility increases of up to 1.4 and 1.8 times the bulk solubility, where as γ-glycine showed upward of an 8 times amplification in the solubility. These MD simulations represent a first attempt at a computational (pre)screening method for the rational design of experiments for future engineering of nanocrystal API formulations.
49
Drug Solubility: Importance and Enhancement Techniques
Ketan T. Savjani, Anuradha Gajjar, Jignasa Savjani · ISRN Pharmaceutics · 2012 · 2K citations · Full text